Kimberly-Clark
KMB · What the business does, what can go wrong, and how options sellers approach it
What it does
Kimberly-Clark makes everyday paper-based and absorbent products for homes and workplaces. Its brands include Huggies and Pull-Ups (diapers and training pants), Kotex (feminine care), Depend (adult incontinence), and Kleenex and Cottonelle (tissues and bathroom products). A professional business supplies washroom, safety and cleaning products to workplaces. It sells in North America and in many markets abroad.
How it makes money
The company sells branded products through retailers, online and distributors. Profit depends on the gap between what it charges and what it costs to make and ship the goods. Its main inputs are wood pulp, plastics-based materials, energy and freight. Its professional business also earns revenue from dispensers and the refills that go in them.
Why investors own it
People tend to keep buying diapers, tissues and incontinence products in good times and bad, so demand is usually steadier than for most industries. Strong brands can give the company some pricing power. It also has a long record of paying dividends, which attracts income-focused investors. Dividends are not guaranteed and can be changed by the board.
What can go wrong
- Input costs, especially pulp, energy and freight, can rise faster than the company can raise prices.
- Retailers' private-label products compete hard on price.
- Falling birth rates can weigh on the diaper category.
- Currency swings and economic trouble abroad can hurt international results.
- Large acquisitions or restructurings can strain execution and the balance sheet.
What to watch
- Organic sales growth, split into price and volume
- Gross margin and input cost trends
- Market share in diapers and tissue
- Cost-savings and restructuring progress
- Free cash flow, dividend coverage and debt levels
- Results in the professional segment and in international markets
Options income angle
KMB options are typically liquid, though thinner than for the largest stocks, so spreads can widen on far-from-the-money and longer-dated contracts. Because the business is steady, implied volatility is often modest, rising around quarterly earnings and during broad market stress.
The caution for premium sellers: low implied volatility means smaller premiums, yet a sharp earnings move can still hit hard. A cash-secured put can leave you owning shares after a drop, and short calls face higher early-assignment risk just before an ex-dividend date.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 12, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Kimberly-Clark's 2025 reported results were weaker, with net sales down 2.1% and income from continuing operations down 24.8%, though adjusted operating profit was in line with the prior year. The larger story is structural. The company has agreed to acquire Kenvue, which would add shares and debt, and plans to move its International Family Care and Professional (IFP) business into a joint venture with Suzano.
How the business did
- Net sales of $16.4 billion declined 2.1%, mainly from divestitures, business exits and currency. Organic sales (which strip out currency and divestitures) rose 1.7%, with volume gains of 2.5% partly offset by lower pricing.
- Operating profit of $2.4 billion decreased 12.9%. Adjusted operating profit of $2.7 billion was in line with the prior year. Adjusted figures exclude items management says do not reflect underlying operations, such as restructuring charges. Diluted earnings per share from continuing operations were $4.86, down 24.2%, while adjusted earnings per share were $6.12 versus $6.16.
- North America net sales of $10.8 billion fell 2.4% as the U.S. private label diaper business was exited. International Personal Care net sales of $5.7 billion fell 0.9%, with currency a drag, and its operating profit decreased 3.6%.
- Cash provided by operations was $2.8 billion versus $3.2 billion. The company paid $1.7 billion in dividends and spent $1.1 billion on capital projects.
- The effective tax rate was 29.2% versus 18.3%, mainly from a valuation allowance on U.S. foreign tax credits tied to the One Big Beautiful Bill Act. IFP results are shown as discontinued operations.
Risks specific to this company
- Kenvue deal may not close. Closing depends on regulatory approvals and other conditions. Either side may walk away if the first merger is not completed by November 2, 2026, subject to extension. A termination fee of $1.136 billion applies in specified circumstances, and stockholder complaints have already been filed.
- Dilution and debt. About 280 million new shares would be issued, leaving existing K-C holders with approximately 54% of the company. Debt was approximately $7.2 billion at year-end, and the filing says combined debt would be substantially greater, which could limit flexibility on dividends and investment.
- Input costs and tariffs. Pulp and petroleum-based materials are volatile and feed directly into diapers, tissue and wipes. The company also absorbed incremental tariff costs in 2025, mostly in North America.
- Retailer power and private label. Large retailers can demand higher trade discounts, and the filing reports growing private label pressure in Baby and Child Care and Family Care.
- Falling birth rates. Baby care sales track birth rates, and declines in China, South Korea and the U.S. have pressured category volume growth.
- Russia. The company runs its sole Russian plant on a limited basis. Russia is approximately 1% to 2% of net global sales, operating profit and total assets, and the filing says those assets could be partly or fully impaired.
What management is watching
- The 2024 Transformation Initiative is expected to finish by the end of 2026. It targets $3.0 billion in total pre-tax gross productivity savings against costs of approximately $1.5 billion pre-tax, and workforce reductions of 4% to 5%.
- Management expects 2026 net input costs, including tariffs, to be broadly in line with 2025. Capital spending is expected to be approximately $1.3 billion.
- The IFP joint venture is expected to close in mid-2026. Suzano's affiliate would buy a 51% interest for approximately $1.7 billion, and the company would keep 49%.
- Management says pricing pressure from competitors and large retailers should continue in the coming year, and it points to innovation and premiumization as its response.
- Investors are pointed to non-GAAP measures: Organic Sales Growth, Adjusted Gross Profit, Adjusted Operating Profit, Adjusted Earnings per Share and Adjusted Effective Tax Rate.
Follow KMB in Kortex
The Kortex app shows KMB's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.